Value investing has created more billionaires than any other strategy, like Warren Buffett, who built his fortune by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between – many stocks that appear cheap often stay that way because they face structural issues.
Identifying genuine bargains from value traps is something many investors struggle with, which is why we started StockStory – to help you find the best companies. That said, here is one value stock with strong fundamentals and two climbing an uphill battle.
Forward P/E Ratio: 12.5x
Pioneering an alternative to traditional metal braces with nearly invisible plastic aligners, Align Technology (NASDAQ:ALGN) designs and manufactures Invisalign clear aligners, iTero intraoral scanners, and dental CAD/CAM software for orthodontic and restorative treatments.
Why Is ALGN Not Exciting?
-
Disappointing clear aligner shipments over the past two years imply it may need to invest in improvements to get back on track
-
Expenses have increased as a percentage of revenue over the last five years as its adjusted operating margin fell by 7.5 percentage points
-
Shrinking returns on capital suggest that increasing competition is eating into the company’s profitability
At $132.82 per share, Align Technology trades at 12.5x forward P/E. Read our free research report to see why you should think twice about including ALGN in your portfolio, it’s free for active Edge members.
Forward P/E Ratio: 12.8x
With a vast inventory of over 300,000 products stocked in distribution centers spanning more than 5.3 million square feet worldwide, Henry Schein (NASDAQ:HSIC) is a global distributor of healthcare products and services primarily to dental practices, medical offices, and other healthcare facilities.
Why Does HSIC Worry Us?
-
Absence of organic revenue growth over the past two years suggests it may have to lean into acquisitions to drive its expansion
-
Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 3.6 percentage points
-
Diminishing returns on capital suggest its earlier profit pools are drying up
Henry Schein’s stock price of $65.19 implies a valuation ratio of 12.8x forward P/E. To fully understand why you should be careful with HSIC, check out our full research report (it’s free for active Edge members).
Forward P/E Ratio: 13.2x
Known for brands such as Egg-Land’s Best and Land O’ Lakes, Cal-Maine (NASDAQ:CALM) produces, packages, and distributes eggs.